Two new compounds, goniothalesacetate (1) and goniothalesdiol A (2) together with goniodiol-7-monoacetate, goniodiol-8-monoacetate, leiocarpin C, liriodenine, griffithazanone A, 4-methyl-2,9,10-(2H)-1-azaanthracencetrione, velutinam and aristolactam BII were isolated and characterized from the stems of Goniothalamus amuyon. Structures of new compounds were determined by spectral analysis.
In the course of our investigation for bioactive compounds from Annonaceae natural resources, [1] [2] [3] [4] we have studied the stems of Goniothalamus amuyon (BLANCO) MERR., which is not only indigenous to southern Taiwan near the coastal region but also the only species of Goniothalamus in Taiwan. The seeds were reported to be useful in the treatment of edema and rheumatism. 5) Literature surveys indicated that two major types of bioactive compounds, styryllactones and acetogenins, have been found from Goniothalamus species. In this study, we report herein the isolation and structure elucidation of two new compounds, goniothalesacetate (1) and goniothaesdiol A (2), together with eight known compounds, include three styryllactones, goniodiol-7-monoacetate, 4) goniodiol-8-monoacetate, 4) leiocarpin C, 6) and five alkaloids, liriodenine, 3) griffithazanone A, 7) 4-methyl-2,9,10-(2H)-1-azaanthracencetrione, 7) velutinam 8) and aristolactam BII. 8) Compound 1 was isolated as yellow oil. The presence of hydroxyl and methoxyl groups were suggested in EI-MS by two fragment peaks at m/z 321 [ 1 H-NMR spectrum, respectively. These groups were also confirmed in the 13 C-NMR spectrum.
Further spectral evidence was required to confirm the structure of 1. The COSY spectrum showed coupling correlations through the sequence of H-2 to H-7 (Fig. 2) . The HBMC spectrum (Fig. 2) showed cross peaks between the aromatic signals (H-2Ј, 6Ј) and C-2, and between H-2 and C-1Ј, which indicated the aromatic ring was connected to C-2. In addition, the HMBC cross peaks between d -6) showed that the methoxyl group was linked to C-6. In addition, a cross peak between d H 5.10 (H-4) and d C 171.7 (C-9) indicated the acetyl group was located on C-4. Accordingly, an ether linkage and a free hydroxyl should be assigned on positions 2, 3, or 5. The 1 H-NMR spectrum of the acetate derivative (3) confirmed that the hydroxyl group was located on C-3 according to the obvious down-field shift of H-3 (from d 4.05 to 5.04) after acetylation of 1. Therefore, a 2,5-ether linkage can be confirmed. The plane structure of 1 was determined as methyl 3-(3-acetoxy-4-hydroxy-5-phenyloxolan-2-yl)-3-methoxypropanoate.
The stereochemistry of 1 was established by the NOESY spectrum. The cross peaks of H-2/H-5 were in agreement with cis-relationship for the tetrahydrofuranal moiety. The presence of a correlation between H-2 and H-4 and without correlation between H-3 and H-5 indicated that H-4 has the same orientation with H-2 and H-5. These correlations showed the relative configuration of H-2/H-3, H-3/H-4, and H-4/H-5 as erythero, threo, and threo. The H-5 and H-6 were also determined to be in the threo configuration as the result of J 5/6 (7.2 Hz) value. 9) In order to determine of the absolute stereochemistry of 1, (R)-and (S)-methoxy fluoromethyl phenylacetic acid (MTPA) esters of 1 (1r, 1s) were prepared. The 1 H-NMR data (see Table 2 ) of 1r and 1s indicated the absolute configuration of C-3 to be R. Thus, the chiral centers of 1 were evidenced as 2R,3R,4S,5S,6R. From the foregoing spectral analyses, the structure 1 was established and named goniothalesacetate.
Compound 2 was isolated as white powder. The coupling correlations through a sequence from H-2 to H-6 were found in the COSY spectrum. The HBMC cross peaks between aromatic signals (H-2Ј, H-6Ј) and C-2 as well as between H-2 and C-1Ј indicated that the aromatic ring was connected to C-2. The HMBC correlations between d H 3.71 and d C 172.3 (C-8) as well as between d 2.74/2.84 (H-7) and d 172.3 (C-8) suggested that the acetic acid methyl ester tail was linked to C-6 as in 1. However, the arrangements of the sequence from H-2 to H-6 are different in NMR spectra with those of 1. On the basis of aforementioned spectral features, tetrahydropyranal central skeleton was proposed.
The stereochemistry of 2 was assigned by analysis of 1 H-NMR coupling constant and circular dichroism. The J 2/3 value (8.0 Hz) indicated an axial-axial position of H-2 and H-3.
10) The observed J 3/4 value was 3.6 Hz, which indicated that H-3 and H-4 should be an axial-equitorial position, and the J 5/6 (8.4, 4.8 Hz) determined the conformation of H-6 as axial. Hence, the relative conformations H-2/H-3 and H-3/H-4 are assigned to be erythero and erythero. In addition, the 11) the ignorable negative cotton effect (De Ϫ0.5) of 2 at the 250 nm region is also ambiguous to the structural elucidation. The Mosher's ester reaction also failed due to the insufficient amount of the sample. Thus, we predicted the absolute stereochemistry should follow the ratiocination in biosynthesis and assign as 2R*,3S*,4S*, and 6R*, respectively, which was named goniothalesdiol A. It is a new-type styryllactone derivative from the genus Goniothalamus.
According to the previous literatures, 12) the possible partial biosynthesis pathway of styryllactones was published. Due to the unusual structural features of 1 and 2, we supposed their possible biogenetic pathway (Fig. 3) . By key hydroxylation procedures (steps a, b) passing through different oxidative cyclization, possible metabolites, including the new compounds 1 and 2, deoxygoniopypyrone, and goniofupyrone, can be generated. In addition to our and previous supposition, 12 ) the biogenetic originals of most styryllactone derivatives from Goniothalamus species can be completed. All proposed approaches were designed on the basis of refs. 12 and 13.
In the biological assay, compound 1 did not show significant inhibition against several cancer cell lines, including Hep2G (human hepatocellular carcinoma), Hep3B (human hepatoma cells), MDA-MB-231 (human breast carcinoma) and MCF-7 (human breast carcinoma) cells. The significant antiplatelet aggregation and cytotoxic activities of other known compounds had been reported in the previous studies.
4,8)

Experimental
Melting points were measured on a Yanagimoto micro-melting point apparatus and were uncorrected. The UV spectra were obtained on a Hitachi 200-20 spectrophotometer in CH 3 OH solution. The IR spectra were recorded on a Mattson Genesis II spectrophotometer.
1 H-NMR (400 MHz) and 13 C-NMR (100 MHz) spectra were recorded with Varian NMR spectrometers. LR-EI-MS were collected on a JEOL JMS-SX/SX 102A mass spectrometer. HR-FAB-MS were collected on a Finnigan/Thermo Quest MAT 95XL mass spectrometer. TLC analysis was carried out on Si gel GF 254 pre-coated plates with detection using 50% H 2 SO 4 followed by heating on a hot plate.
Plant Material Fresh stems of G. amuyon (BLANCO) MERR. were collected in Hengchun, Pingtung Hsien, Taiwan in September, 2001. The voucher specimen (Goniothalamus 1) is deposited in the Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan.
Extraction and Isolation The procedures employed for extraction and partition were described previously.
4) The CHCl 3 (Fr. C-1) residue was subjected to silica gel (2.5 kg, 11ϫ53 cm) column chromatography, gradient eluting with n-hexane/CHCl 3 /CH 3 OH. The collected fractions were combined on the basis of their TLC characteristics to give 15 fractions after removal of solvents. Fraction 6, eluted with pure CHCl 3 , was further separated by CC over silica gel with CHCl 3 to give velutinam (1.6 mg), liriodenine (6.2 mg), griffithazanone A (2.3 mg), 4-methyl-2,9,10,-(2H)-l-azaanthracencetrione (1.9 mg) and aristolactam BII (3.5 mg). Fraction 8 eluted with CHCl 3 and purified by preparative TLC to give goniodiol-7-monoacetate (1.1 mg) and goniodiol-8-monoacetate (0.9 mg). Fraction 9 was rechromatographed on silica gel eluting with CHCl 3 to afford 1 (45 mg).
The CHCl 3 layer (25 g) (Fr. C-2) was subjected to silica gel column chromatography (630 g, 7ϫ27 cm) and eluted with gradient mixtures of CHCl 3 /CH 3 OH. The eluates were combined into 10 fractions on the basis of TLC monitoring. Fraction 9 was further purified by RP-HPLC (Hypersil ODS column, i.d. 21.2ϫ250 mm, CH 3 CN-water, 20 : 80, flow rate 3.5 ml/min; UV detector set at 210 nm) to give 2 (1.2 mg) and leiocarpin C (1.4 mg) (Hypersil ODS column, i.d. 21.2ϫ250 mm, CH 3 OH-CH 3 CNwater, 10 : 10 : 80, flow rate 3.5 ml/min; UV detector set at 210 nm).
Goniothalesacetate (1) 
Preparation of (R)-and (S)-MTPA Esters of 1
Compound 1 (4.5 mg) was dried completely under vaccum. Deuterated pyridine (0.5 ml) and (R)-(Ϫ)-a-methoxy-a-(trifluoromethyl) phenylacetyl chloride (15 mg) were added under a N 2 gas stream. The mixture was stirred 2 h at room temperature and purified by HPLC with CH 3 CN/H 2 O to give (R)-MTPA ester 1r (3.2 mg). By the same procedure, the (S)-MTPA ester 1s (2.5 mg) was prepared. 1 H-NMR data of 1r and 1s, see Table 2 .
